Detalles de la búsqueda
1.
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Cancer
; 128(10): 1913-1920, 2022 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35226357
2.
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER-positive HER2-negative early breast cancer.
Cancer Sci
; 112(4): 1369-1375, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544932
3.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Breast Cancer Res Treat
; 189(2): 455-461, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131830
4.
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer.
Ann Surg Oncol
; 28(1): 310-319, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32583195
5.
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
Breast Cancer Res
; 21(1): 88, 2019 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387614
6.
Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
Breast Cancer Res Treat
; 176(1): 75-85, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949799
7.
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer.
Breast Cancer Res Treat
; 173(3): 533-543, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30361874
8.
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
Breast Cancer Res Treat
; 174(3): 627-637, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30607631
9.
Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components.
Am J Pathol
; 188(5): 1106-1112, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454754
10.
Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein.
Bioorg Med Chem
; 27(11): 2228-2234, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023557
11.
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 171(1): 33-41, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728801
12.
Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.
Breast Cancer Res Treat
; 167(1): 49-58, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28905136
13.
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
Ann Surg Oncol
; 25(9): 2603-2611, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978372
14.
Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Support Care Cancer
; 26(3): 933-945, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063390
15.
Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-ß-hydroxylase expression.
Cancer Sci
; 108(12): 2454-2461, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28985022
16.
Reply to "Survival analysis in a prediction model for early systemic recurrence in breast cancer".
Cancer
; 128(20): 3745-3746, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969034
17.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Lancet
; 388(10063): 2997-3005, 2016 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908454
18.
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.
Breast Cancer Res Treat
; 163(2): 231-240, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283903
19.
A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Breast Cancer Res Treat
; 166(1): 55-68, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28702892
20.
Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology Trials.
Oncology
; 92(5): 243-254, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28219073